Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide

Blood (2022) 139 (10): 1452–1468.

https://doi.org/10.1182/blood.2021013443

Published: 2022

Includes: Supplemental data

Journal Articles

Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study

Blood (2021) 138 (16): 1429–1440.

https://doi.org/10.1182/blood.2021011719

Published: 2021

Includes: Supplemental data

Journal Articles

Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapy

Blood (2021) 137 (13): 1832–1835.

https://doi.org/10.1182/blood.2020006245

Published: 2021

Includes: Supplemental data

Journal Articles

Pilot Initiative of Fitness Testing for Treatment Selection in Elderly Acute Myelogenous Leukemia (AML)

Heather J Male, MD, Tara L. Lin, MD, Andrea Sitek, Scott Kramer, PT, DPT, Joseph McGuirk, DO

Blood (2016) 128 (22): 2400.

https://doi.org/10.1182/blood.V128.22.2400.2400

Published: 2016

Journal Articles

A Prospective Randomized Double Blind Phase 3 Clinical Trial of Anti- T Lymphocyte Globulin (ATLG) to Assess Impact on Chronic Graft-Versus-Host Disease (cGVHD) Free Survival in Patients Undergoing HLA Matched Unrelated Myeloablative Hematopoietic Cell Transplantation (HCT)

Blood (2016) 128 (22): 505.

https://doi.org/10.1182/blood.V128.22.505.505

Published: 2016

Journal Articles

Retrospective Analysis of Post-Transplant Complications in Autologous Hematopoietic Cell Transplantation Patients Receiving Hyperbaric Oxygen Therapy

Haitham Abdelhakim, MD, Sajjad Akbar Bhatti, MBBS, Amy Rose Cantilena, BS, Tara L. Lin, MD, Siddhartha Ganguly, MD, Anurag K. Singh, MD, Sunil Abhyankar, MD, Brea Lipe, MD, Joseph McGuirk, DO, Dennis Allin, MD, Leyla Shune, MD, Omar Aljitawi, MD

Blood (2016) 128 (22): 5816.

https://doi.org/10.1182/blood.V128.22.5816.5816

Published: 2016

Journal Articles

NPM1-TYK2 Fusion Is an Oncogene and a Novel HSP90-Client Protein

Sudhakiranmayi Kuravi, M.S., Preethi Kunchala, M.S., Siddhartha Ganguly, MD, Sunil Abhyankar, MD, Yogen Saunthararajah, MD, Kojo S. J. Elenitoba-Johnson, MD, Jensen Roy, MD, Joseph McGuirk, DO, Ramesh Balusu, PhD

Blood (2016) 128 (22): 4127.

https://doi.org/10.1182/blood.V128.22.4127.4127

Published: 2016

Journal Articles

Impact of Hyperbaric Oxygen Treatment on Time to Transfusion Independency Post-UCB Transplant

Amy Rose Cantilena, BS, Tara L. Lin, MD, Siddhartha Ganguly, MD, Leyla Shune, MD, Anurag K. Singh, MD, Sunil Abhyankar, MD, Jonathan Mahnken, PhD, Dennis Allin, Joseph McGuirk, DO, Omar S. Aljitawi, MD

Blood (2015) 126 (23): 4333.

https://doi.org/10.1182/blood.V126.23.4333.4333

Published: 2015

Journal Articles

Outcomes of Autologous Stem Cell Transplantation for Lymphoma in the Elderly: A Single Center Experience

Ghulam Rehman Mohyuddin, Shaun DeJarnette, Clint Divine, Tara L Lin, MD, Leyla Shune, MD, Sunil Abhyankar, MD, Omar S. Aljitawi, MD, Siddhartha Ganguly, MD, Joseph McGuirk, DO, Anurag K. Singh, MD

Blood (2015) 126 (23): 5505.

https://doi.org/10.1182/blood.V126.23.5505.5505

Published: 2015

Journal Articles

Heat Shock Factor 1 Promotes NF-Kb and B-Cell Signaling in a Preclinical Model of Chronic Lymphocytic Leukemia

Rekha Rao, PhD, Trisha Home, M.S, Abdulraheem Yacoub, MD, Huidong Shi, PhD, Ashok Saluja, PhD, Joseph McGuirk, DO, Siddhartha Ganguly, MD

Blood (2015) 126 (23): 5297.

https://doi.org/10.1182/blood.V126.23.5297.5297

Published: 2015

Journal Articles

Final Results of the First-in-Human Clinical Study Incorporating Hyperbaric Oxygen into Umbilical Cord Blood Transplantation

Omar S. Aljitawi, MD, Siddhartha Ganguly, MD, Tara L. Lin, MD, Shana Palla, Chris Lominska, Qing Yu, Singh Anurag, Sunil Abhyankar, MD, Dennis Allin, Mary Eapen, MBBS, Joseph McGuirk, DO

Blood (2015) 126 (23): 1909.

https://doi.org/10.1182/blood.V126.23.1909.1909

Published: 2015

Journal Articles

Blinatumomab for Relapsed/Refractory Acute Lymphocytic Leukemia: A Single Center Experience

Tara L. Lin, MD, Zahra Mahmoudjafari, PharmD, Omar S. Aljitawi, MD, Anurag K. Singh, MD, Leyla Shune, MD, Siddhartha Ganguly, MD, Sunil Abhyankar, MD, Joseph McGuirk, DO

Blood (2015) 126 (23): 4912.

https://doi.org/10.1182/blood.V126.23.4912.4912

Published: 2015

Journal Articles

Hyperbaric Oxygen Therapy Improves Post-Transplant Umbilical Cord Blood Engraftment

Omar S. Aljitawi, MD, Xiao Yinghua, Tara Lin, MD, Jeff Eskew, PhD, Nikhil Parelkar, Megan Swink, Jeff Radel, PhD, Joseph McGuirk, DO, Linheng Li, PhD, George Vielhauer, Pharm D, PhD

Blood (2012) 120 (21): 4663.

https://doi.org/10.1182/blood.V120.21.4663.4663

Published: 2012

Journal Articles

Propylene Glycol-Free Melphalan Induces Higher Remission Rates in Multiple Myeloma Patients Undergoing Autologous Transplantation

Omar S. Aljitawi, MD, Anna Ludlow, Siddhartha Ganguly, MD, Sunil Abhyankar, MD, Tara Lin, MD, J.D Pipkin, PhD, Joseph McGuirk, DO

Blood (2012) 120 (21): 4551.

https://doi.org/10.1182/blood.V120.21.4551.4551

Published: 2012

Journal Articles

Pre-Clinical Efficacy of Combined Therapy with Novel β-Catenin Antagonist BC2059 and Histone Deacetylase Inhibitor Against Cultured and Primary AML Blast Progenitor Cells

Kapil Bhalla, MD, Warren Fiskus, Ph.D., Stephen K. Horrigan, PhD, Sunil Abhyankar, MD, Joseph McGuirk, DO, Sunil Sharma, MD

Blood (2012) 120 (21): 287.

https://doi.org/10.1182/blood.V120.21.287.287

Published: 2012

Journal Articles

Pre-Clinical Efficacy of Combined Therapy with LSD1 Antagonist SP-2509 and Pan-Histone Deacetylase Inhibitor Against AML Blast Progenitor Cells

Warren Fiskus, Ph.D., Sunil Sharma, M.D., Sunil Abhyankar, MD, Joseph McGuirk, DO, David J. Bearss, PhD, Kapil Bhalla, MD

Blood (2012) 120 (21): 868.

https://doi.org/10.1182/blood.V120.21.868.868

Published: 2012

Journal Articles

Targeting Mutant Nucleophosmin 1 (NPM1) Induces Differentiation, Loss of Survival and Sensitizes AML Cells to All-Trans Retinoic Acid, Cytarbine and FLT3 Antagonists

Ramesh Balusu, PhD, Josiah Cox, Stacey Hembruff, MS, Warren Fiskus, BSc, PhD, Rekha Rao, PhD, Uma Mudunuru, MS, Ruben Reyes, MD, Siddhartha Ganguly, MD, Sunil Abhyankar, MD, Heather Male, MD, Allan Fleming, MD, Casey B Williams, Pharm.D., Joseph McGuirk, DO, Kapil N. Bhalla, MD

Blood (2011) 118 (21): 733.

https://doi.org/10.1182/blood.V118.21.733.733

Published: 2011

Journal Articles

Treatment with β-Catenin Antagonist BC2059 Exerts Single Agent Efficacy and Exerts Improved Activity with Tyrosine Kinase Inhibitor (TKI) or Pan-Histone Deacetylase (HDAC) Inhibitor Against Human CML and Myeloproliferative Neoplasm (MPN) Progenitor Cells

Warren Fiskus, PhD, Jacqueline Smith, MS, Uma Mudunuru, MS, Stacey Hembruff, MS, Ruben Reyes, MD, Sunil Abhyankar, MD, Joseph McGuirk, DO, Omar S. Aljitawi, MD, Siddhartha Ganguly, MD, Stephen K. Horrigan, PhD, Sunil Sharma, MD, Kapil N. Bhalla, MD

Blood (2011) 118 (21): 65.

https://doi.org/10.1182/blood.V118.21.65.65

Published: 2011

Journal Articles

Phase IIa, Open-Label, Randomized, Pharmacokinetic Comparative, Cross-Over Study of Melphalan HCl for Injection (Propylene Glycol-Free) and Alkeran for Injection for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation

Omar S. Aljitawi, MD, Sunil Abhyankar, MD, Siddhartha Ganguly, MD, Karen Wolfe, Kelly Daniels, Ron Marks, Mike Ferree, J.D. Pipkin, PhD, Joseph McGuirk, DO

Blood (2011) 118 (21): 4512.

https://doi.org/10.1182/blood.V118.21.4512.4512

Published: 2011

Journal Articles

Activity of Allosteric, Switch-Pocket, ABL/FLT3 Kinase Inhibitor DCC2036 Against Cultured and Primary AML Progenitors with FLT-ITD or FLT3 Kinase Domain Mutations

Warren Fiskus, BSc, PhD, Catherine C. Smith, MD, Jacqueline Smith, MS, Scott C. Wise, MS, Elisabeth Lasater, PhD, Lauren E. Damon, Sara Salerno, BS, Allan Fleming, MD, Ruben Reyes, MD, Siddhartha Ganguly, MD, Mark S. Berger, MD, Tom J. Rutkoski, Ph.D, Joseph McGuirk, DO, Neil Shah, MD, PhD, Kapil N. Bhalla, MD

Blood (2011) 118 (21): 2611.

https://doi.org/10.1182/blood.V118.21.2611.2611

Published: 2011

NARROW

HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide

Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study

Outcomes of patients with large B-cell lymphoma progressing after axicabtagene ciloleucel therapy

Pilot Initiative of Fitness Testing for Treatment Selection in Elderly Acute Myelogenous Leukemia (AML)

A Prospective Randomized Double Blind Phase 3 Clinical Trial of Anti- T Lymphocyte Globulin (ATLG) to Assess Impact on Chronic Graft-Versus-Host Disease (cGVHD) Free Survival in Patients Undergoing HLA Matched Unrelated Myeloablative Hematopoietic Cell Transplantation (HCT)

Retrospective Analysis of Post-Transplant Complications in Autologous Hematopoietic Cell Transplantation Patients Receiving Hyperbaric Oxygen Therapy

NPM1-TYK2 Fusion Is an Oncogene and a Novel HSP90-Client Protein

Impact of Hyperbaric Oxygen Treatment on Time to Transfusion Independency Post-UCB Transplant

Outcomes of Autologous Stem Cell Transplantation for Lymphoma in the Elderly: A Single Center Experience

Heat Shock Factor 1 Promotes NF-Kb and B-Cell Signaling in a Preclinical Model of Chronic Lymphocytic Leukemia

Final Results of the First-in-Human Clinical Study Incorporating Hyperbaric Oxygen into Umbilical Cord Blood Transplantation

Blinatumomab for Relapsed/Refractory Acute Lymphocytic Leukemia: A Single Center Experience

Hyperbaric Oxygen Therapy Improves Post-Transplant Umbilical Cord Blood Engraftment

Propylene Glycol-Free Melphalan Induces Higher Remission Rates in Multiple Myeloma Patients Undergoing Autologous Transplantation

Pre-Clinical Efficacy of Combined Therapy with Novel β-Catenin Antagonist BC2059 and Histone Deacetylase Inhibitor Against Cultured and Primary AML Blast Progenitor Cells

Pre-Clinical Efficacy of Combined Therapy with LSD1 Antagonist SP-2509 and Pan-Histone Deacetylase Inhibitor Against AML Blast Progenitor Cells

Targeting Mutant Nucleophosmin 1 (NPM1) Induces Differentiation, Loss of Survival and Sensitizes AML Cells to All-Trans Retinoic Acid, Cytarbine and FLT3 Antagonists

Treatment with β-Catenin Antagonist BC2059 Exerts Single Agent Efficacy and Exerts Improved Activity with Tyrosine Kinase Inhibitor (TKI) or Pan-Histone Deacetylase (HDAC) Inhibitor Against Human CML and Myeloproliferative Neoplasm (MPN) Progenitor Cells

Phase IIa, Open-Label, Randomized, Pharmacokinetic Comparative, Cross-Over Study of Melphalan HCl for Injection (Propylene Glycol-Free) and Alkeran for Injection for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation

Activity of Allosteric, Switch-Pocket, ABL/FLT3 Kinase Inhibitor DCC2036 Against Cultured and Primary AML Progenitors with FLT-ITD or FLT3 Kinase Domain Mutations

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only